Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression function

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• Oestrogen receptor alpha (ERalpha) is crucial for breast cancer prognosis and treatment.
• ERalpha regulates cell proliferation and differentiation by controlling gene expression.
• ERalpha's role in repressing proinvasive genes is key to better patient outcomes.

Purpose of the Study:

• To investigate the mechanisms by which ERalpha represses proinvasive gene expression.
• To determine how tumor necrosis factor alpha (TNFalpha) and PI3-kinase signaling affect ERalpha function.
• To elucidate the link between ERalpha stability, its transrepression activity, and breast cancer invasiveness.

Main Methods:

• Utilized ERalpha-negative MDA-MB-231 breast cancer cells engineered to overexpress ERalpha.
• Employed ERalpha-positive MCF-7 and ZR-75-1 cell lines for comparative analysis.
• Investigated the impact of TNFalpha and PI3-kinase modulation on ERalpha stability and transrepression activity.

Main Results:

• ERalpha was shown to transrepress the expression of the proinvasive gene interleukin 6 (IL-6) in ERalpha-overexpressing cells.
• Tumor necrosis factor alpha (TNFalpha) and PI3-kinase activation were found to reduce ERalpha protein stability.
• Reduced ERalpha stability correlated with a loss of its transrepression function.

Conclusions:

• TNFalpha signaling or PI3-kinase activation can decrease ERalpha protein levels in breast cancer cells.
• This decrease in ERalpha leads to diminished transrepression of proinvasive genes.
• The findings suggest a mechanism by which ERalpha loss promotes an invasive cancer phenotype.